Authors: A. Scampini, S. Gallorini, B.C. Baudner, G. Palladino, M. Singh, D.T. O’Hagan, S. Kommareddy
Affilation: Novartis, United States
Pages: 352 - 355
Keywords: Influenza vaccine
As a part of reformulating influenza vaccines by novel delivery technologies it is essential to work with concentrated antigens. The purpose of this study was to concentrate seasonal influenza monobulks, to characterize the concentrated antigens in vitro, and to evaluate the concentrated antigens for in vivo immunogenicity.